Page last updated: 2024-08-23

mifepristone and drospirenone

mifepristone has been researched along with drospirenone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Baldacci, C; Caruso, A; Flamini, MI; Fu, XD; Garibaldi, S; Genazzani, AR; Giretti, MS; Mannella, P; Sanchez, AM; Simoncini, T1

Other Studies

2 other study(ies) available for mifepristone and drospirenone

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Drospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors.
    Human reproduction (Oxford, England), 2007, Volume: 22, Issue:8

    Topics: Aldosterone; Androstadienes; Androstenes; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Estradiol; Flavonoids; Humans; Medroxyprogesterone Acetate; Mifepristone; Nitric Oxide; Nitric Oxide Synthase Type III; Progesterone; Receptors, Mineralocorticoid; Receptors, Progesterone; Signal Transduction; Time Factors; Wortmannin

2007